Mycobacterial and Nocardial Infections in the Compromised Host

  • Harvey B. Simon


Among the broad range of pathogenic and opportunistic microorganisms that can affect the immunologically impaired host are members of various mycobacterial and nocardial species. These organisms are often grouped together because of a common tinctorial property: both Mycobacteria and Nocardia spp. generally appear acid fast when stained with the traditional Ziehl-Neelson procedure or with modified acid-fast staining techniques. Despite this similarity, these organisms behave quite differently in biologic, clinical, and therapeutic terms, and as a result they require separate discussion here.


Active Tuberculosis Pulmonary Tuberculosis Mycobacterial Infection Immunosuppressed Patient Positive Skin Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Karlson AG, Can- DT: Tuberculosis caused by Mycobacterium bovis: Report of six cases 1954–1968. Ann Intern Med 73: 979, 1970.PubMedGoogle Scholar
  2. 2.
    BCG Vaccines. MMWR 28 (21): 241, 1979.Google Scholar
  3. 3.
    BCG: Bad news from India. (Editorial.) Lancet 1: 73, 1980.Google Scholar
  4. 4.
    Adu D, Evans DB, Millard PR, et al: Renal transplantation in leprosy. Br Med J 2: 280, 1973.PubMedCrossRefGoogle Scholar
  5. 5.
    Wolinsky E: Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119: 107, 1979.PubMedGoogle Scholar
  6. 6.
    Mackaness GB: Resistance to intracellular infection. J Infect Dis 123: 439, 1971.PubMedCrossRefGoogle Scholar
  7. 7.
    Simon HB, Sheagren JN: Cellular immunity in vitro. Immunologically mediated enhancement of macrophage bactericidal capacity. J Exp Med 133: 1377, 1971.PubMedCrossRefGoogle Scholar
  8. 8.
    Smith JA, Reichman LB: Lymphocyte transformation: An aid in the diagnosis of tuberculosis in patients with nonreactive skin tests. Am Rev Respir Dis 106: 194, 1972.PubMedGoogle Scholar
  9. 9.
    Zeitz SJ, Ostrow JH, VanArsdel PP Jr: Humoral and cellular immunity in the anergic tuberculosis patient. J Allergy Clin Immunol 51: 20, 1974.CrossRefGoogle Scholar
  10. 10.
    Ellner JJ: Suppressor adherent cells in human tuberculosis. J Immunol 121: 2573, 1978.PubMedGoogle Scholar
  11. 11.
    Stead WW, Bates JH: Evidence of a “silent” bacillemia in primary tuberculosis. Ann Intern Med 74: 559, 1971.PubMedGoogle Scholar
  12. 12.
    Stead WW: Pathogenesis of the sporadic case of tuberculosis. N Engl J Med 277: 1008, 1967.PubMedCrossRefGoogle Scholar
  13. 13.
    MacGregor RR, Clark LW, Bass F: The significance of isolating low numbers of mycobacterium tuberculosis in culture of sputum specimens. Chest 68: 518, 1975.Google Scholar
  14. 14.
    Rosenthal T, Pitlik S, Mitchaeli D: Fatal undiagnosed tuberculosis in hospitalized patients. J Infect Dis 131: S51, 1975.PubMedCrossRefGoogle Scholar
  15. 15.
    Williams DM, Krick JA, Remington JS: Pulmonary infection in the compromised host. Part II. Am Rev Respir Dis, 114: 593, 1976.PubMedGoogle Scholar
  16. 16.
    Gopalakrishnan P, Miller JE, McLaughlin JS: Pulmonary tuberculosis and coexisting carcinoma: A 10-year experience and review of the literature. Am Surg 41: 405, 1975.PubMedGoogle Scholar
  17. 17.
    Neff TA, Ashbaugh DG, Petty TL: Miliary tuberculosis and carcinoma of the lung: Successful treatment with chemotherapy and resection. Am Rev Respir Dis 105: 111, 1972.PubMedGoogle Scholar
  18. 18.
    Roviaro GC, Sartori F, Calabro F, et al: The association of pleural mesothelioma and tuberculosis. Am Rev Respir Dis 126: 569, 1982.PubMedGoogle Scholar
  19. 19.
    Kaplan MH, Armstrong D, Rosen P: Tuberculosis complicating neoplastic disease: A review of 201 cases. Cancer 33: 850, 1974.PubMedCrossRefGoogle Scholar
  20. 20.
    Feld R, Bodey GP, Groschel D: Mycobacteriosis in patients with malignant disease. Arch Intern Med 136: 67, 1976.PubMedCrossRefGoogle Scholar
  21. 21.
    Ortbals DW, Man JJ: A comparative study of tuberculous and other mycobacterial infections and their associations with malignancy. Am Rev Respir Dis 117: 39, 1978.PubMedGoogle Scholar
  22. 22.
    Levine AS, Graw RG, Young RC: Management of infec tions in patients with leukemia and lymphoma: Current concepts and experimental approaches. Semin Hematol 9: 141, 1972.PubMedGoogle Scholar
  23. 23.
    Morrow LB, Anderson RE: Active tuberculosis in leukemia. Arch Pathol Lab Med 79: 484, 1965.Google Scholar
  24. 24.
    Pitlik SD, Fainstein V, Bodey GP: Tuberculosis mimicking cancer-A reminder. Am J Med 76: 822, 1984.PubMedCrossRefGoogle Scholar
  25. 25.
    Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 84: 304, 1976.PubMedGoogle Scholar
  26. 26.
    Bovornkitti S, Kangsadal P, Sathirapat P, et al: Reversion and reconversion rate of tuberculin skin reactions in correlation with the use of prednisone. Chest 38: 51, 1960.CrossRefGoogle Scholar
  27. 27.
    MacGregor RR, Sheagren JN, Lipsett MB, et al: Alternate-day prednisone therapy. N Engl J Med 280: 1427, 1969.PubMedCrossRefGoogle Scholar
  28. 28.
    Busey JF, Fenger EPK, Hepper NG, et al: Adrenal corticosteroids and tuberculosis. Am Rev Respir Dis 97: 484, 1968.Google Scholar
  29. 29.
    Schatz M, Patterson R, Kloner R, et al: The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population. Ann Inter Med 84: 261, 1976.Google Scholar
  30. 30.
    Walsh SD, Grant WB: Corticosteroids in treatment of chronic asthma. Br Med J 2: 796, 1966.PubMedCrossRefGoogle Scholar
  31. 31.
    Smyllie HC, Connolly CK: Incidence of serious complications of corticosteroid therapy in respiratory disease. Thorax 23: 571, 1968.PubMedCrossRefGoogle Scholar
  32. 32.
    Sahn, SA, Lakshminarayan S: Tuberculosis after corticosteroid therapy. Br J Dis Chest 70: 195, 1976.PubMedCrossRefGoogle Scholar
  33. 33.
    Batata MA: Pulmonary tuberculosis in a renal transplant recipient. JAMA 237: 1465, 1977.PubMedCrossRefGoogle Scholar
  34. 34.
    Kurzrock R, Zander A, Vellekoop L, et al: Mycobacterial pulmonary infections after allogenic bone marrow transplantation. Am J Med 77: 35, 1984.PubMedCrossRefGoogle Scholar
  35. 35.
    Ascher NL, Simmons RL, Marker S, et al: Tuberculous joint disease in transplant patients. Am J Surg 135: 853, 1978.PubMedCrossRefGoogle Scholar
  36. 36.
    Ortuno J, Teruel JL, Marcen R, et al: Primary intestinal tuberculosis following renal transplantation. Nephron 31: 59, 1982.PubMedCrossRefGoogle Scholar
  37. 37.
    Neff TA, Hudgel DW: Miliary tuberculosis in a renal transplant recipient. Am Rev Respir Dis 108: 677, 1973.PubMedGoogle Scholar
  38. 38.
    Rattazzi LC, Simmons RL, Spanos PK, et al: Successful management of miliary tuberculosis after renal transplantation. Am J Surg 130: 359, 1975.PubMedCrossRefGoogle Scholar
  39. 39.
    Graybill JR, Silva J Jr, Fraser DW, et al: Disseminated mycobacteriosis due to Mycobacterium abscessus in two recipients of renal homografts. Am Rev Respir Dis 109: 4, 1974.PubMedGoogle Scholar
  40. 40.
    Fraser DW, Buxton AE, Naji A, et al: Disseminated Mycobacterium kansasii infection presenting as cellulitis in a recipient of a renal homograft, Am Rev Respir Dis 112: 125, 1975.PubMedGoogle Scholar
  41. 41.
    Gombert ME, Goldstein EJ, Con-ado ML, et al: Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med 94: 486, 1981.PubMedGoogle Scholar
  42. 42.
    Davis BR, Brumbach J, Sanders WJ, et al: Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med 97: 723, 1982.Google Scholar
  43. 43.
    Lichtenstein IH, MacGregor RR: Mycobacterial infections in renal transplant recipients: Report of five cases and review of the literature. Rev Infect Dis 5: 216, 1983.PubMedCrossRefGoogle Scholar
  44. 44.
    Pradhan RP, Katz LA, Nidus BD, et al: Tuberculosis in dialyzed patients. JAMA 229: 798, 1974.PubMedCrossRefGoogle Scholar
  45. 45.
    Band JD, Ward JI, Fraser DW, et al: Peritonitis due to a Mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis 145: 9, 1982.PubMedCrossRefGoogle Scholar
  46. 46.
    Nontuberculous mycobacterial infections in hemodialysis patients-Louisiana, 1982. MMWR 32 (18): 245, 1983.Google Scholar
  47. 47.
    Raff, MJ, Waterman NG, Barnwell PA, et al: Infectious Diseases complicating renal transplantation: A survey and recommendations for prevention, recognition, and management. South Med J 69: 1603, 1976.PubMedCrossRefGoogle Scholar
  48. 48.
    Duma RJ, Eickhoff TC, Remington JS, et al: Panel discussion on infections in transplant patients. Transplant Proc 4: 717, 1972.Google Scholar
  49. 49.
    Thomas PA Jr, Manko MA: Chemoprophylaxis for the prevention of tuberculosis in the immunosuppressed renal allograft recipient. Transplantation 20: 76, 1975.PubMedCrossRefGoogle Scholar
  50. 50.
    Stead WW, Kerby GR, Schlueter DP, et al: The clinical spectrum of primary tuberculosis in adults. Ann Intern Med 68: 731, 1968.PubMedGoogle Scholar
  51. 51.
    Huseby JS, Hudson LD: Miliary tuberculosis and adult respiratory distress syndrome. Ann Intern Med 85: 609, 1976.PubMedGoogle Scholar
  52. 52.
    Miller WT, MacGregor RR: Tuberculosis: Frequency of unusual radiographic findings. AJR 130: 867, 1978.PubMedGoogle Scholar
  53. 53.
    Husen L, Fulkerson LL, DelVecchio E, et al: Pulmonary tuberculosis with negative findings on chest X-ray films: A study of 40 cases. Chest 60: 540, 1971.PubMedCrossRefGoogle Scholar
  54. 54.
    Alvarez S, McCabe WR: Extrapulmonary tuberculosis revisited: A review of experience at Boston City and other hospitals. Medicine (Baltimore) 63: 25, 1984.Google Scholar
  55. 55.
    Sahn SA, Neff TA: Miliary tuberculosis. Am J Med 56: 495, 1974.CrossRefGoogle Scholar
  56. 56.
    Munt PW: Miliary tuberculosis in the chemotherapy era with a clinical review in 69 American adults. Medicine (Baltimore) S1: 139, 1972.Google Scholar
  57. 57.
    Hinman AR: Tuberculous meningitis at Cleveland Metropolitan General Hospital 1959 to 1963. Am Rev Respir Dis 85: 670, 1967.Google Scholar
  58. 58.
    O’Toole RD, Thornton GF, Mukherjee DPH, et a1: Dexamethasone in tuberculous meningitis. Ann Intern Med 70: 39, 1969.PubMedGoogle Scholar
  59. 59.
    Weiss W, Flippin HF: The prognosis of tuberculous meningitis in the isoniazid era. Am J Med Sci 242: 423, 1961.PubMedCrossRefGoogle Scholar
  60. 60.
    Rooney JJ, Crocco JA, Lyons HA: Tuberculous pericarditis. Ann Intern Med 72: 73, 1970.PubMedGoogle Scholar
  61. 61.
    Hageman JH, D’Esopo ND, Glenn WWL: Tuberculosis of the pericardium. N Eng! J Med 270: 327, 1964.CrossRefGoogle Scholar
  62. 62.
    Berger HW, Mejia E: Tuberculous pleurisy. Chest 63: 88, 1973.PubMedCrossRefGoogle Scholar
  63. 63.
    Borhanmanesh F, Hekmat K, Vaezzadeh K, et al: Tuberculous peritonitis: Prospective study of 32 cases in Iran. Ann Intern Med 76: 567, 1972.PubMedGoogle Scholar
  64. 64.
    Simon HB, Weinstein AJ, Pasternack MS, et al: Genitourinary tuberculosis: Clinical features in a general hospital population. Am J Med 63: 410, 1977.PubMedCrossRefGoogle Scholar
  65. 65.
    Wallace R, Cohen AS: Tuberculous arthritis: A report of two cases with review of biopsy and synovial fluid findings. Am Med 61: 277, 1976.CrossRefGoogle Scholar
  66. 66.
    Davidson PT, Horowitz I: Skeletal tuberculosis: A review with patient presentations and discussion. Am J Med 48: 77, 1970.PubMedCrossRefGoogle Scholar
  67. 67.
    Iles PB, Emerson PA: Tuberculous lymphadenitis. Br Med J 1: 143, 1974.PubMedCrossRefGoogle Scholar
  68. 68.
    Coburn RJ, England M, Samson DM, et al: Tuberculosis and blood disorders. Br J Haematol 25: 793, 1973.PubMedCrossRefGoogle Scholar
  69. 69.
    Lowther CP: Leukemia and tuberculosis. Ann Intern Med 51: 52, 1959.PubMedGoogle Scholar
  70. 70.
    Glasser RM, Walker RI, Herion JC: The significance of hematologic abnormalities in patients with tuberculosis. Arch Intern Med 125: 691, 1970.PubMedCrossRefGoogle Scholar
  71. 71.
    Jung A, Graziano M, Waldvogel F, et al: Unusual presentation of tuberculosis. Br Med J 2: 97, 1974.PubMedCrossRefGoogle Scholar
  72. 72.
    Engstrom PF, Dewey GC, Barrett 0: Disseminated Mycobacterium kansasii infection. Am J Med 52: 533, 1972.PubMedCrossRefGoogle Scholar
  73. 73.
    Gruhl VR, Reese MH: Disseminated atypical mycobacterial disease presenting as “leukemia.” J Clin Pathol 55: 206, 1971.Google Scholar
  74. 74.
    Manes JL, Blair OM: Disseminated Mycobacterium kansasii infection complicating hairy cell leukemia. JAMA 236: 1878, 1976.PubMedCrossRefGoogle Scholar
  75. 75.
    Grillo-Lopez Ai, Rivera E, Castillo-Staab M, et al: Disseminated M. kansasii infection in a patient with chronic granulocytic leukemia. Cancer 28: 476, 1971.PubMedCrossRefGoogle Scholar
  76. 76.
    McNutt DR, Fudenberg HH: Disseminated scotochromogen infection and unusual myeloproliferative disorder. Ann Intern Med 75: 737, 1971.PubMedGoogle Scholar
  77. 77.
    Pottage JC Jr, Harris AA, Trenholme GM, et al: Disseminated Mycobacterium chelonei infection: A report of two cases. Am Rev Respir Dis 126: 720, 1982.PubMedGoogle Scholar
  78. 78.
    Pierce PF, DeYoung DR, Roberts GD: Mycobacteremia and the new blood culture systems. Ann Intern Med 99: 786, 1983.PubMedGoogle Scholar
  79. 79.
    Wallace RJ Jr, Swenson JM, Silcox VA, et al: Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 5: 657, 1983.PubMedCrossRefGoogle Scholar
  80. 80.
    Horsburgh CR Jr, Mason UG III, Farhi DC, et al: Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. Medicine (Baltimore) 64: 36, 1985.Google Scholar
  81. 81.
    Zamorano J, Tompsett R: Disseminated atypical mycobacterial infection and pancytopenia. Arch Intern Med 121: 424, 1968.PubMedCrossRefGoogle Scholar
  82. 82.
    Kilbridge TM, Gonnella JS, Bolan JT: Pancytopenia and death: Disseminated anonymous mycobacterial infection. Arch Intern Med 120: 38, 1967.PubMedCrossRefGoogle Scholar
  83. 83.
    Hagmar B, Kutti J, Lundin P, et al: Disseminated infection caused by Mycobacterium kansasii. Acta Med Scand 186: 93, 1969.CrossRefGoogle Scholar
  84. 84.
    Listwan WJ, Roth DA, Tsung SH, et al: Disseminated Mycobacterium kansasii infection with pancytopenia and interstitial nephritis. Ann Intern Med 83: 70, 1975.PubMedGoogle Scholar
  85. 85.
    Oswald NC: Acute tuberculosis and granulocytic disorders. Br Med J 1: 1489, 1963.CrossRefGoogle Scholar
  86. 86.
    Medd WE, Hayhoe FGJ: Tuberculosis miliary necrosis with pancytopenia. Q J Med 24: 351, 1955.PubMedGoogle Scholar
  87. 87.
    Eickhoff TC: The current status of BCG immunization against tuberculosis. Annu Rev Med 28: 411, 1977.PubMedCrossRefGoogle Scholar
  88. 88.
    Bast RC, Zbar B, Borsos T, et al: BCG and cancer. N Engl J Med 290: 1413, 1974.PubMedCrossRefGoogle Scholar
  89. 89.
    Aungst CW, Sokal JE, Jager BV: Complications of BCG vaccination in neoplastic disease. Ann Intern Med 82: 666, 1975.PubMedGoogle Scholar
  90. 90.
    Sparks FC, Silverstein MJ, Hunt JS, et al: Complications of BCG immunotherapy in patients with cancer. N Engl J Med 289: 827, 1973.PubMedCrossRefGoogle Scholar
  91. 91.
    Rosenberg SA, Seipp C, Sears HF: Clinical and immunologic studies of disseminated BCG infection. Cancer 41: 1771, 1978.PubMedCrossRefGoogle Scholar
  92. 92.
    Pitchenik AE, Cole C, Russell BW, et al: Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in South Florida. Ann Intern Med 101: 641, 1984.PubMedGoogle Scholar
  93. 93.
    Greene JB, Sidhu GS, Lewin S, et al: Mycobacterium avi-um-intracellulare: A cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med 97: 539, 1982.PubMedGoogle Scholar
  94. 94.
    Poon M-C, Landay A, Prasthofer EF, et al: Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium-intracellulare infection in a previously healthy patient with classic hemophilia. Ann Intern Med 98: 287, 1983.PubMedGoogle Scholar
  95. 95.
    Elliott JL, Hoppes WL, Platt MS, et al: The acquired immunodeficiency syndrome and Mycobacterium avium-intracellulare bacteremia in a patient with hemophilia. Ann Intern Med 98: 290, 1983.PubMedGoogle Scholar
  96. 96.
    Fainstein V, Bolivar R, Mavligit G: Disseminated infection due to Mycobacterium avium-intracellulare in a homosexual man with Kaposi’s sarcoma. J Infect Dis 145: 586, 1982.PubMedCrossRefGoogle Scholar
  97. 97.
    Zakowski P, Fligiel S, Berlin GW, et al: Disseminated My-cobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency. JAMA 248: 2980, 1982.PubMedCrossRefGoogle Scholar
  98. 98.
    Winter SM, Bernard EM, Gold JWM, et al: Humoral response to disseminated infection by Mycobacterium aviumintracellulare in acquired immunodeficiency syndrome and hairy cell leukemia. J Infect Dis 151: 523, 1985.PubMedCrossRefGoogle Scholar
  99. 99.
    Macher AM, Kovacs JA, Gill V, et al: Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med 99: 782, 1983.PubMedGoogle Scholar
  100. 100.
    Wong B, Edwards FF, Kiehn TE, et al: Continuous highgrade Mycobacterium avium-intracellulare bacteremia in patients with acquired immune deficiency syndrome. Am J Med 78: 35, 1985.PubMedCrossRefGoogle Scholar
  101. 101.
    Damsker B, Bottone EJ: Mycobacterium avium-intra-cellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: Concepts regarding acquisition and pathogenesis. J Infect Dis 151: 179, 1985.PubMedCrossRefGoogle Scholar
  102. 102.
    Eng RHK, Forrester C, Smith SM, et al: Mycobacterium xenopi infection in a patient with acquired immunodeficiency syndrome. Chest 86: 145, 1984.PubMedCrossRefGoogle Scholar
  103. 103.
    Pitchenik AE, Rubinson HA: The radiographic appearance of tuberculosis in patients with the acquired immuno deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 131: 393, 1985.PubMedGoogle Scholar
  104. 104.
    International Union against Tuberculosis Committee on Prophylaxis: Efficacy of various durations of isoniazid preven-tive therapy for tuberculosis: Five years of follow-up in the IUAT trial. Bull WHO 60: 555, 1982.Google Scholar
  105. 105.
    Au FC, Webber B, Rosenberg SA: Pulmonary granulomas induced by BCG. Cancer 41: 2209, 1978.PubMedCrossRefGoogle Scholar
  106. 106.
    Barlow PB, Black M, Brummer DL, et al: Preventative therapy of tuberculous infection. Am Rev Respir Dis 110:371, 1974.Google Scholar
  107. 107.
    Millar JW, Home NW: Tuberculosis in immunosuppressed patients. Lancet 1: 1176, 1979.PubMedCrossRefGoogle Scholar
  108. 108.
    Thomas PA, Mozes MF, Jonasson O: Hepatic dysfunction during isoniazid chemoprophylaxis in renal allograft recip ients. Arch Surg 114: 597, 1979.PubMedCrossRefGoogle Scholar
  109. 109.
    Berne TV, Chatterjee SN, Craig JR, et al: Hepatic dysfunc tion in recipients of renal allografts. Surg Gynecol Obstet 141: 171, 1975.Google Scholar
  110. 110.
    Ware AJ, Luby JP, Eigenbrodt EH, et al: Spectrum of liver disease in renal transplant recipients. Gastroenterology 68: 755, 1975.Google Scholar
  111. 111.
    Johnston RF, Wildrick KH: “State of the art” review. The mpact of chemotherapy on the care of patients with tuber culosis. Am Rev Respir Dis 109: 636, 1974.PubMedGoogle Scholar
  112. 112.
    Bailey WC, Raleigh JW, Turner JAP: American Thoracic Society: Treatment of mycobacterial disease. Am Rev Respir Dis 115: 185, 1977.Google Scholar
  113. 113.
    Angel JH: Short-course chemotherapy in pulmonary tuber culosis: A controlled trial by the British Thoracic and Tuber culosis Association. Lancet 2: 1102, 1976.Google Scholar
  114. 114.
    Dutt AK, Moers D, Stead WW: Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Am J Med 77: 233, 1984.PubMedCrossRefGoogle Scholar
  115. 115.
    Hudson LD, Sbarbaro JA: Twice weekly tuberculosis che motherapy. JAMA 223: 139, 1973.PubMedCrossRefGoogle Scholar
  116. 116.
    Murray JP, Finegold SM, Froman S, et al: The changing spectrum of nocardiosis. Am Rev Respir Dis 83: 315, 1961.PubMedGoogle Scholar
  117. 117.
    Beaman BL, burnside J, Edwards B, et al: Nocardial infections in the United States, 1972–1974. J Infect Dis 134: 286, 1976.PubMedCrossRefGoogle Scholar
  118. 118.
    Smego RA Jr, Gallis HA: The clinical spectrum of Nocardia brasiliensis infection in the United States. Rev Infect Dis 6 (2): 164, 1984.PubMedCrossRefGoogle Scholar
  119. 119.
    Robboy SJ, Vickery AL Jr.: Tinctorial and morphologic properties distinguishing actinomycosis and nocardiosis. N Engl J Med 282: 593, 1970.PubMedCrossRefGoogle Scholar
  120. 120.
    Stevens DA, Pier AC, Beaman BL, et al: Laboratory evaluation of an outbreak of nocardiosis in immunocompromised hosts. Am J Med 71: 926, 1981.CrossRefGoogle Scholar
  121. 121.
    Palmer DL, Harvey, RL, Wheeler JK: Diagnostic and therapeutic considerations in nocardia asteroides infection, Medicine (Baltimore) 53: 391, 1974.CrossRefGoogle Scholar
  122. 122.
    Holtz HA, Lavery DP, Kapila R: Actinomycetales infection in the acquired immunodeficiency syndrome. Ann Intern Med 102 (2): 2–3, 1985.Google Scholar
  123. 123.
    Simpson GL, Stinson EB, Egger MJ, et a1: Nocardial infections in the immunocompromised host: a detailed study in a defined population. Rev Infect Dis 3: 492, 1981.PubMedCrossRefGoogle Scholar
  124. 124.
    Filice GA, Beaman BL, Remington JS: Effects of activated macrophages on Nocardia asteroides. Infect Immun 27: 643, 1980.PubMedGoogle Scholar
  125. 125.
    Kahn FW, Gornick CC, Tofte RW: Primary cutaneous Nocardia asteroides infection with dissemination. Am J Med 70: 859, 1981.PubMedCrossRefGoogle Scholar
  126. 126.
    Raich RA, Casey F, Hall WH: Pulmonary and cutaneous nocardiosis. Am Rev Respir Dis 83: 505, 1961.PubMedGoogle Scholar
  127. 127.
    Frazier AR, Rosenow EC, Roberts GD: Nocardiosis: A review of 25 cases occurring during 24 months. Mayo Clin Proc 50: 657, 1975.PubMedGoogle Scholar
  128. 128.
    Young LS, Armstrong D, Blevins A, et al: Nocardia asteroides infection complicating neoplastic disease. Am J Med 50: 356, 1971.PubMedCrossRefGoogle Scholar
  129. 129.
    Katz P, Fauci AS: Nocardia asteroides sinusitis: Presentation as a trimethoprim-sulfamethoxazole responsive fever of unknown origin. JAMA 238: 2397, 1977.PubMedCrossRefGoogle Scholar
  130. 130.
    Balikian JP, Herman PG, Kopit S: Pulmonary nocardiosis. Radiology 126: 569, 1978.PubMedGoogle Scholar
  131. 131.
    Chavez CM, Causey WA, Conn JH: Constrictive pericarditis due to infection with Nocardia asteroides. Chest 61: 79, 1972.CrossRefGoogle Scholar
  132. 132.
    Neu HC, Silva M, Hazen E, et al: Necrotizing nocardial pneumonitis. Ann Intern Med 66: 274, 1967.PubMedGoogle Scholar
  133. 133.
    Roberts GD, Brewer NS, Hermans PE: Diagnosis of nocardiosis by blood culture. Mayo Clin Proc 49: 293, 1974.PubMedGoogle Scholar
  134. 134.
    Avram MM, Nair SR, Lipner HI, et al: Persistent nocardemia following renal transplantation, JAMA 239: 2779, 1978.PubMedCrossRefGoogle Scholar
  135. 135.
    Petersen DL, Hudson LD, Sullivan K: Disseminated Nocardia caviae with positive blood cultures. Arch Intern Med 138: 1164, 1978.PubMedCrossRefGoogle Scholar
  136. 136.
    Bach MC, Sabath LD, Finland M: Susceptibility of Nocardia asteroides to 45 antimicrobial agents in vitro. Antimicrob Agents Chemother 3: 1, 1973.PubMedCrossRefGoogle Scholar
  137. 137.
    Wallace RJ JR., Septimus EJ, Musher DM, et al: Disk diffusion susceptibility testing of Nocardia species. J Infect Dis 135: 568, 1977.PubMedCrossRefGoogle Scholar
  138. 138.
    Bennett JE, Jennings AE: Factors influencing susceptibility of Nocardia species to trimethoprim—sulfamethoxazole. Antimicrob Agents Chemother 13: 624, 1978.PubMedCrossRefGoogle Scholar
  139. 139.
    Maderazo EG, Quintilliani R: Treatment of nocardial infection with trimethoprim and sulfamethoxazole. Am J Med 57: 671, 1974.PubMedCrossRefGoogle Scholar
  140. 140.
    Cook FV, Farrar WE Jr: Treatment of Nocardia asteroides infection with trimethoprim-sulfamethoxazole. South Med J 71: 512, 1978.PubMedCrossRefGoogle Scholar
  141. 141.
    Wallace RJ Jr, Septimus EJ, Williams TW Jr, et al: Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis 4: 315, 1982.CrossRefGoogle Scholar
  142. 142.
    Bach MC, Monaco AP, Finland M: Pulmonary nocardiosis: Therapy with minocycline and with erythromycin plus ampicillin. JAMA 224: 1378, 1973.PubMedCrossRefGoogle Scholar
  143. 143.
    Petersen EA, Nash ML, Mammana RB, et al: Minocycline treatment of pulmonary nocardiosis. JAMA 250: 930, 1983.PubMedCrossRefGoogle Scholar
  144. 144.
    Yogev R, Greenslade T, Firlit CF, et al: Successful treatment of Nocardia asteroides infection with amikacin. J. Pediatr 96: 771, 1980.PubMedCrossRefGoogle Scholar
  145. 145.
    Haburchak DR, Jeffery B, Higbee JW, et al: Infections caused by rhodochrous. Am J Med 65: 298, 1978.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Harvey B. Simon
    • 1
    • 2
  1. 1.Infectious Disease UnitMassachusetts General HospitalBostonUSA
  2. 2.Department of MedicineHarvard Medical SchoolBostonUSA

Personalised recommendations